Lafora body disease: a case of progressive myoclonic epilepsy
- PMID: 33370974
- PMCID: PMC7757443
- DOI: 10.1136/bcr-2020-236971
Lafora body disease: a case of progressive myoclonic epilepsy
Abstract
Progressive myoclonic epilepsy (PME) is a progressive neurological disorder. Unfortunately, until now, no definitive curative treatment exists; however, it is of utmost importance to identify patients with PME. The underlying aetiology can be pinpointed if methodological clinical evaluation is performed, followed by subsequent genetic testing. We report a case of PME that was diagnosed as Lafora body disease. This case emphasises that, suspecting and identifying PME is important so as to start appropriate treatment and reduce the probability of morbidity and prognosticate the family.
Keywords: drugs: CNS (not psychiatric); epilepsy and seizures; memory disorders.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials